Condition: Hemostasis · Hemostatic Techniques · Sponsor: Ethicon, Inc.
The objective of this clinical investigation is to evaluate the safety and efficacy of ETHIZIA to control minimal, mild, or moderate soft tissue bleeding during open surgery when compared to SURGICEL Original in the percentage of cases achieving hemostasis at 3 minutes after product application, and without re-bleeding up to 10 minutes after application.
This description comes directly from the study's public registry record.
Patricia Schleckser · +1 908 808 6670 · pschleck@its.jnj.com
Dr Richard Kocharian · +16096423787 · rkochar1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Keck Hospital of USC | Los Angeles, California, United States | Recruiting |
| Washington University Barnes Jewish Hospital | St Louis, Missouri, United States | Recruiting |
| Capital Health Medical Center - Hopewell | Pennington, New Jersey, United States | Recruiting |
| New York Presbyterian - Weill Cornell Medical Ctr | New York, New York, United States | Recruiting |
| UT Health East Texas EMS Air 1 | Tyler, Texas, United States | Recruiting |
| Intermountain Medical Center | Murray, Utah, United States | Recruiting |
| UMC Radboud | Nijmegen, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06664788